These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 31715099)
1. Enzymatic Preparation of 2'-5',3'-5'-Cyclic Dinucleotides, Their Binding Properties to Stimulator of Interferon Genes Adaptor Protein, and Structure/Activity Correlations. Novotná B; Vaneková L; Zavřel M; Buděšínský M; Dejmek M; Smola M; Gutten O; Tehrani ZA; Pimková Polidarová M; Brázdová A; Liboska R; Štěpánek I; Vavřina Z; Jandušík T; Nencka R; Rulíšek L; Bouřa E; Brynda J; Páv O; Birkuš G J Med Chem; 2019 Dec; 62(23):10676-10690. PubMed ID: 31715099 [TBL] [Abstract][Full Text] [Related]
2. Detection of Cyclic Dinucleotides by STING. Du XX; Su XD Methods Mol Biol; 2017; 1657():59-69. PubMed ID: 28889286 [TBL] [Abstract][Full Text] [Related]
3. Discovery of isonucleotidic CDNs as potent STING agonists with immunomodulatory potential. Dejmek M; Šála M; Brazdova A; Vanekova L; Smola M; Klíma M; Břehová P; Buděšínský M; Dračínský M; Procházková E; Zavřel M; Šimák O; Páv O; Boura E; Birkuš G; Nencka R Structure; 2022 Aug; 30(8):1146-1156.e11. PubMed ID: 35690061 [TBL] [Abstract][Full Text] [Related]
4. Enzymatic Synthesis of 3'-5', 3'-5' Cyclic Dinucleotides, Their Binding Properties to the Stimulator of Interferon Genes Adaptor Protein, and Structure/Activity Correlations. Novotná B; Holá L; Staś M; Gutten O; Smola M; Zavřel M; Vavřina Z; Buděšínský M; Liboska R; Chevrier F; Dobiaš J; Boura E; Rulíšek L; Birkuš G Biochemistry; 2021 Dec; 60(48):3714-3727. PubMed ID: 34788017 [TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Biochemical and Biological Evaluation of Novel 7-Deazapurine Cyclic Dinucleotide Analogues as STING Receptor Agonists. Vavřina Z; Perlíková P; Milisavljević N; Chevrier F; Smola M; Smith J; Dejmek M; Havlíček V; Buděšínský M; Liboska R; Vaneková L; Brynda J; Boura E; Řezáčová P; Hocek M; Birkuš G J Med Chem; 2022 Oct; 65(20):14082-14103. PubMed ID: 36201304 [TBL] [Abstract][Full Text] [Related]
6. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy. Oduro PK; Zheng X; Wei J; Yang Y; Wang Y; Zhang H; Liu E; Gao X; Du M; Wang Q Acta Pharm Sin B; 2022 Jan; 12(1):50-75. PubMed ID: 35127372 [TBL] [Abstract][Full Text] [Related]
7. 2',3'-Cyclic GMP-AMP Dinucleotides for STING-Mediated Immune Modulation: Principles, Immunotherapeutic Potential, and Synthesis. Shang M; Lu K; Guan W; Cao S; Ren M; Zhou C ChemMedChem; 2022 Jan; 17(2):e202100671. PubMed ID: 34807508 [TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Biological Evaluation of (2',5' and 3'5'-Linked) cGAMP Analogs that Activate Stimulator of Interferon Genes (STING). Xie X; Liu J; Wang X Molecules; 2020 Nov; 25(22):. PubMed ID: 33198423 [TBL] [Abstract][Full Text] [Related]
10. Structural basis of STING binding with and phosphorylation by TBK1. Zhang C; Shang G; Gui X; Zhang X; Bai XC; Chen ZJ Nature; 2019 Mar; 567(7748):394-398. PubMed ID: 30842653 [TBL] [Abstract][Full Text] [Related]
11. Cyclic Dinucleotides Inhibit Osteoclast Differentiation Through STING-Mediated Interferon-β Signaling. Kwon Y; Park OJ; Kim J; Cho JH; Yun CH; Han SH J Bone Miner Res; 2019 Jul; 34(7):1366-1375. PubMed ID: 30779854 [TBL] [Abstract][Full Text] [Related]
13. Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING. Rueckert C; Rand U; Roy U; Kasmapour B; Strowig T; Guzmán CA FASEB J; 2017 Jul; 31(7):3107-3115. PubMed ID: 28396343 [TBL] [Abstract][Full Text] [Related]
14. No magnesium is needed for binding of the stimulator of interferon genes to cyclic dinucleotides. Smola M; Birkus G; Boura E Acta Crystallogr F Struct Biol Commun; 2019 Sep; 75(Pt 9):593-598. PubMed ID: 31475926 [TBL] [Abstract][Full Text] [Related]
15. Vinylphosphonate-based cyclic dinucleotides enhance STING-mediated cancer immunotherapy. Dejmek M; Brazdova A; Otava T; Polidarova MP; Klíma M; Smola M; Vavrina Z; Buděšínský M; Dračínský M; Liboska R; Boura E; Birkuš G; Nencka R Eur J Med Chem; 2023 Nov; 259():115685. PubMed ID: 37567057 [TBL] [Abstract][Full Text] [Related]
16. Crystal structures of porcine STING Cong X; Yuan Z; Du Y; Wu B; Lu D; Wu X; Zhang Y; Li F; Wei B; Li J; Wu J; Xu S; Wang J; Qi J; Shang G; Gu L J Biol Chem; 2019 Jul; 294(30):11420-11432. PubMed ID: 31167783 [TBL] [Abstract][Full Text] [Related]
17. Small molecules targeting the innate immune cGAS‒STING‒TBK1 signaling pathway. Ding C; Song Z; Shen A; Chen T; Zhang A Acta Pharm Sin B; 2020 Dec; 10(12):2272-2298. PubMed ID: 33354501 [TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides. Yi G; Brendel VP; Shu C; Li P; Palanathan S; Cheng Kao C PLoS One; 2013; 8(10):e77846. PubMed ID: 24204993 [TBL] [Abstract][Full Text] [Related]
20. Chemical synthesis, purification, and characterization of 3'-5'-linked canonical cyclic dinucleotides (CDNs). Wang C; Hao M; Qi Q; Chen Y; Hartig JS Methods Enzymol; 2019; 625():41-59. PubMed ID: 31455536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]